—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Bruker Corporation (BRKR) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for BRKR, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.82 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How BRKR has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.82 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Bruker Corporation moved 0.82% on average · correlation 0.13 · higher than 78% of US names
  • Beta, last 3 months 0.24 less rate-sensitive lately than over the year
  • On the 10 worst bond days 0.00% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +7.26% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against BRKR on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Bruker Corporation

BRKR in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Bruker builds scientific instruments used in research and diagnostics, organised into four segments covering nuclear magnetic resonance and imaging tools, mass spectrometry and molecular diagnostics kits, nanoscale imaging and metrology tools such as atomic force microscopes and X-ray systems, and superconducting wire materials. Its customers span academic labs, biopharma companies, and industrial and clinical testing sites. It is headquartered in Billerica, Massachusetts.
Where it sits in the stack
Bruker carries no seat in our Rubin index and sits instead in our broader Healthcare sleeve, under medical devices and life-science tools; it supplies research and diagnostic instruments rather than components for AI infrastructure.
Who it is priced against
No formal peer group is set for it yet; the market usually compares it with larger life-science instrument makers such as Thermo Fisher Scientific and Agilent Technologies.
Why Closelooknet tracks it
It holds a seat in the Russell 1000 but carries no Closelooknet score and has not appeared in the diary's quotes so far.
What the diary watches
Whether demand across its life-science and diagnostics segments holds up as research and biopharma budgets shift.

Bruker Corporation (BRKR) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 0.31%, quarterly · last 0.0500 USD on 2026-09-21

Dividends and capital return

What BRKR pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.20 USD per share · a 0.31% yield on the 2026-09-25 close 4 distributions, paid quarterly 2026-09-25
  • Change on the year +0.2% against the prior twelve months prior twelve months 0.20 USD per share
  • Last distribution 0.0500 USD per share as the price series records it, within days of the ex-date 2026-09-21
  • By calendar year 2023: 0.0500 USD (partial) · 2024: 0.15 USD · 2025: 0.20 USD · 2026: 0.15 USD to date first distribution recorded in the three-year window: 2023-11-30

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Bruker Corporation (BRKR)?

Bruker Corporation trades as BRKR on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is BRKR in a Closelooknet index?

Not currently — Bruker Corporation is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does BRKR trade against its moving averages?

Uptrend stack intact: Trades +9.8% vs the 50-day and +31.4% vs the 200-day average, 1.7% below the 52-week high and +113.8% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Bruker Corporation trade when bond yields rise?

Over the past year Bruker Corporation had a beta of 0.82 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 78% of US names. On the 10 sessions in which long bonds fell most it moved 0.00% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Bruker Corporation do?

Bruker builds scientific instruments used in research and diagnostics, organised into four segments covering nuclear magnetic resonance and imaging tools, mass spectrometry and molecular diagnostics kits, nanoscale imaging and metrology tools such as atomic force microscopes and X-ray systems, and superconducting wire materials. Its customers span academic labs, biopharma companies, and industrial and clinical testing sites. It is headquartered in Billerica, Massachusetts. No formal peer group is set for it yet; the market usually compares it with larger life-science instrument makers such as Thermo Fisher Scientific and Agilent Technologies.

Where does Bruker Corporation sit in the AI build-out?

Bruker carries no seat in our Rubin index and sits instead in our broader Healthcare sleeve, under medical devices and life-science tools; it supplies research and diagnostic instruments rather than components for AI infrastructure. It holds a seat in the Russell 1000 but carries no Closelooknet score and has not appeared in the diary's quotes so far.

Does Bruker Corporation pay a dividend?

Bruker Corporation has paid 0.20 USD per share over the last twelve months, paid quarterly, a trailing yield of 0.31% on the 2026-09-25 close; the last distribution recorded in the price series was 0.0500 USD on 2026-09-21. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for BRKR, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.